People living with overweight or obesity are more likely to experience knee osteoarthritis (OA). Losing just 10% of body weight has been shown to help reduce knee pain and improve knee function and is often the first treatment doctors recommend.1-3

We are researching if a GLP-1 RA study medicine can help improve symptoms of knee osteoarthritis / knee OA in people living with overweight or obesity.

 

Participating in these studies

We invite you to explore our clinical trials for people living with knee OA and overweight or obesity. With your help, we can advance research that may expand treatment options for people looking for ways to manage their weight and knee OA symptoms.

The study medicine is a GLP-1 RA (glucagon-like peptide-1 receptor agonist). It mimics the effects of a hormone in your body called GLP-1 that helps control your appetite and blood sugar. The study medicine may help people lose weight by increasing a feeling of fullness after eating, slowing down digestion, and regulating blood sugar levels. 

Before you decide to participate in one of our clinical trials, the study doctor and their team will review the clinical trial details with you, including what you can expect during the clinical trial, the length of participation, and potential risks and benefits.

Each clinical trial will have its own unique requirements for who may participate (eligibility criteria). To learn more about the requirements for a clinical trial that is actively recruiting, visit the clinical trial’s webpage below. Only the study staff can determine if you qualify to enroll in a clinical trial.

What to expect

If you decide to join one of the Vesper-OA studies, your participation will last about 63 to 66 weeks and includes up to 18 visits.

You will be randomly assigned (like pulling a number out of a hat) to receive either the study medicine or a placebo (no active medicine). Both are given as injections under the skin.

Your health and knee OA symptoms will be carefully monitored throughout the study. You will also receive guidance on diet, exercise, and lifestyle from a team of weight loss specialists, and a variety of tools to support you every step of the way.

There is no cost to participate, and health insurance is not required. You may be reimbursed for study-related expenses, such as parking and other transportation costs.

References
  1.  Atukorala I, Makovey J, Lawler L, et al. Is there a dose response relationship between weight loss and symptom improvement in persons with knee osteoarthritis? Arthritis Care Res. 2016;68(8):1106-1114. doi: 10.1002/acr.22805 
  2. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465-474. doi:10.1002/acr.21596
  3. Messier SP, Mihalko SL, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: The IDEA Randomized Clinical Trial. JAMA. 2013;310(12):1263-1273. doi:10.1001/jama.2013.277669

Continue exploring

How clinical trials work

Protecting your safety & privacy

Steps to join a clinical trial

FAQs